Literature DB >> 11122914

Current issues in the economics of depression management.

D Thompson1, E Richardson.   

Abstract

In this paper, we present a systematic review of the literature on current issues in the economics of depression management, focusing on studies within three distinct areas of interest: 1) the clinical and economic outcomes of alternative patterns of antidepressant use; 2) the impact of depression and antidepressant therapy on the costs of general medical-care services; and 3) the effects of depression and associated benefits of antidepressant therapy on worker productivity. Our review suggests that 1) patterns of antidepressant use are important predictors of symptom improvement, relapse/recurrence, and costs of care, and that use patterns vary according to the antidepressant received as initial therapy; 2) patients with depression have higher costs of general medical-care services compared with their nondepressed peers, and that treatment of depression may reduce these costs; and 3) depression can result in productivity losses via increased rates of absenteeism and short-term disability as well as via impaired on-the-job performance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11122914     DOI: 10.1007/s11920-999-0021-1

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  27 in total

1.  SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic study.

Authors:  T R Hylan; L Meneades; W H Crown; J A Sacristan; I Gilaberte; A L Montejo
Journal:  J Affect Disord       Date:  1999 Jan-Mar       Impact factor: 4.839

Review 2.  Pharmacotherapy of depressive disorders. A consensus statement. WHO Mental Health Collaborating Centres.

Authors: 
Journal:  J Affect Disord       Date:  1989 Sep-Oct       Impact factor: 4.839

3.  The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression.

Authors:  C A Melfi; A J Chawla; T W Croghan; M P Hanna; S Kennedy; K Sredl
Journal:  Arch Gen Psychiatry       Date:  1998-12

Review 4.  Health economic evaluations of antidepressants: a review.

Authors:  T R Hylan; D P Buesching; G D Tollefson
Journal:  Depress Anxiety       Date:  1998       Impact factor: 6.505

5.  SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis.

Authors:  T R Hylan; W H Crown; L Meneades; J H Heiligenstein; C A Melfi; T W Croghan; D P Buesching
Journal:  Med Care       Date:  1999-04       Impact factor: 2.983

Review 6.  Fluoxetine. A pharmacoeconomic review of its use in depression.

Authors:  M I Wilde; P Benfield
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

7.  Workplace performance effects from chronic depression and its treatment.

Authors:  E R Berndt; S N Finkelstein; P E Greenberg; R H Howland; A Keith; A J Rush; J Russell; M B Keller
Journal:  J Health Econ       Date:  1998-10       Impact factor: 3.883

8.  The role of SSRI antidepressants for treating depressed patients in the California Medicaid (Medi-Cal) program.

Authors:  J S McCombs; M B Nichol; G L Stimmel
Journal:  Value Health       Date:  1999 Jul-Aug       Impact factor: 5.725

9.  What does treatment of depression really cost?

Authors:  T W Croghan; R L Obenchain; W E Crown
Journal:  Health Aff (Millwood)       Date:  1998 Jul-Aug       Impact factor: 6.301

10.  Depression and somatization: a review. Part I.

Authors:  W Katon; A Kleinman; G Rosen
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

View more
  4 in total

1.  Negative attitudes and affect do not predict elective hysterectomy: a prospective analysis from the Study of Women's Health Across the Nation.

Authors:  Carolyn J Gibson; Joyce T Bromberger; Gerson E Weiss; Rebecca C Thurston; MaryFran Sowers; Karen A Matthews
Journal:  Menopause       Date:  2011-05       Impact factor: 2.953

Review 2.  Reducing the societal burden of depression: a review of economic costs, quality of care and effects of treatment.

Authors:  Julie M Donohue; Harold Alan Pincus
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 3.  The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research.

Authors:  Patrick E McKnight; Todd B Kashdan
Journal:  Clin Psychol Rev       Date:  2009-02-07

4.  Behavioural activation by mental health nurses for late-life depression in primary care: a randomized controlled trial.

Authors:  Noortje Janssen; Marcus J H Huibers; Peter Lucassen; Richard Oude Voshaar; Harm van Marwijk; Judith Bosmans; Mirjam Pijnappels; Jan Spijker; Gert-Jan Hendriks
Journal:  BMC Psychiatry       Date:  2017-06-26       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.